Related Experiment Videos
Cardiovascular complications in patients with diabetic nephropathy receiving pharmacological versus renal replacement
Irena Głowińska1, Janusz Grochowski, Jolanta Małyszko
1Dialysis Center, Maków Mazowiecki, Poland.
Insights
Diabetic nephropathy patients undergoing hemodialysis face increased cardiovascular risks and complications. Hemodialysis appears to worsen outcomes for these individuals.
Area of Science:
- Nephrology
- Cardiology
- Diabetology
Background:
- Diabetic nephropathy is a major complication of diabetes mellitus, leading to renal replacement therapy.
- Cardiovascular complications are the primary cause of mortality in patients with diabetic nephropathy.
Purpose of the Study:
- To assess how hemodialysis impacts cardiovascular risk factors.
- To determine the frequency of cardiovascular complications in diabetic nephropathy patients undergoing hemodialysis.
Main Methods:
- Compared four groups: hemodialyzed non-diabetic nephropathy, hemodialyzed diabetic nephropathy, predialysis renal failure, and predialysis diabetic nephropathy.
- Evaluated laboratory parameters, blood pressure, ECG, echocardiography, and prevalence of cardiovascular diseases.
- Assessed dialysis adequacy (Kt/V).
Main Results:
- Hemodialyzed diabetic nephropathy patients showed lower blood counts, less severe calcium-phosphate issues, higher triglycerides, and lower HDL cholesterol.
- Obesity, ischemic heart disease, and peripheral arterial obstructive disease were more prevalent in hemodialyzed diabetic nephropathy patients.
- Myocardial hypertrophy, arrhythmias, impaired contractility, myocardial infarction, and heart failure were more common in hemodialyzed patients irrespective of renal disease cause.
Conclusions:
- Patients with diabetic nephropathy have a higher risk of cardiovascular complications.
- Hemodialysis exacerbates cardiovascular complications and negatively impacts outcomes in diabetic nephropathy patients.
Introduction:
Diabetic nephropathy is a significant complication of diabetes mellitus and one of the major causes of renal replacement therapy. Cardiovascular complications are predominant causes of death in these patients.
Objectives:
To evaluate the influence of hemodialysis on cardiovascular risk factors and on their frequency in diabetic nephropathy patients.
Patients And Methods:
4 groups of renal failure patients were studied. Group 1 consisted of 71 hemodialyzed patients with non-diabetic nephropathy. Group 2 consisted of 29 hemodialyzed patients with diabetic nephropathy. Group 3 consisted of 50 patients with renal failure in the predialysis period (glomerular filtration rate < 60 ml/min). Group 4 consisted of 50 non-dialyzed patients with diabetic nephropathy in the pre-dialysis period. Complete blood count, blood gas, blood urea nitrogen, creatinine, glucose, lipidogram, electrolytes, parathormone, iron and dialysis adequacy (Kt/V) were assessed. Arterial blood pressure, resting ECG, echocardiography, body mass index, ankle-arm index, the prevalence of ischemic heart disease, myocardial infarction and chronic heart failure (NYHA classification) were also evaluated. RESULTS. In hemodialyzed patients with diabetic nephropathy lower complete blood count, less severe calcium-phosphate disorders, higher triglycerides and lower high-density lipoproteins cholesterol, with more frequent obesity, ischemic heart disease and peripheral arterial obstructive disease were found. Myocardial hypertrophy, cardiac arrhythmias, contractility disturbances, myocardial infarction and chronic heart failure were more common in the hemodialyzed patients, regardless of the cause of the renal disease.
Conclusions:
The risk factor for cardiovascular complications is greater in patients with diabetic nephropathy. Hemodialysis increases the frequency of cardiovascular complications in these patients and adversely affects the outcomes.
Related Concept Videos
Diabetic Nephropathy
Heart Failure Drugs: Diuretics
Diabetic Retinopathy
Chronic Kidney Disease IV: Nursing Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...